AGP Executive Report
Last update: 10 hours agoHospital-at-home care: Sidra Medicine launched “Paediatric Private Home Visits: Wellness and Vaccinations,” bringing routine checkups and childhood immunizations to eligible kids at home after clinical review. Patient access in education: The Philippines’ DepEd and Philippine Children’s Medical Center signed an agreement for the first hospital-based learning continuity program for children with long-term health conditions, using modular and bedside instruction. Clinical research updates: Innovent expanded its Phase 3 MarsLight-11 trial of IBI363/TAK-928 to include non-squamous NSCLC; Tiziana Life Sciences dosed first participants in its intranasal foralumab Phase 2a ALS trial; Pharmazz completed enrollment in a Phase 4 sovateltide study in acute ischemic stroke. Safety and systems: A coroner warned Preston and Chorley heart patients are “at risk” from slow transfers to Lancashire Cardiac Centre. Public health and regulation: Kenya’s medicines regulator called for tighter supply-chain controls to keep substandard and falsified products out. Community health wins: Augusta Regional Airport’s “Meet A Machine” raised $11K+ for a children’s hospital, alongside a blood drive.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.